T Cells + Cytotoxic Function in Human CD8 MHC Class I Receptors and Acquisition of Coordinated Expression of Ig-Like Inhibitory
暂无分享,去创建一个
M. Bonneville | J. Moreau | É. Vivier | J. Delfraissy | S. Ugolini | J. Déchanet-Merville | A. Venet | P. Merville | Nicolas Anfossi | V. Pitard | M. Peyrat | Jean-Marc Doisne | D. Bossy | O. Bonnaud
[1] A. Kaser,et al. Expansion and Function of CD8+ T Cells Expressing Ly49 Inhibitory Receptors Specific for MHC Class I Molecules1 , 2004, The Journal of Immunology.
[2] Eric Vivier,et al. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future , 2004, Nature Reviews Immunology.
[3] S. Chouaib,et al. CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling. , 2003, Cancer research.
[4] L. Moretta,et al. HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[5] P. Bjorkman,et al. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor , 2003, Nature Immunology.
[6] S. Olofsson,et al. LIR-1 expression on lymphocytes, and cytomegalovirus disease in lung-transplant recipients , 2003, The Lancet.
[7] Marc Dalod,et al. Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection. , 2003, The Journal of infectious diseases.
[8] E. Remmerswaal,et al. Proliferation Requirements of Cytomegalovirus-Specific, Effector-Type Human CD8+ T Cells1 , 2002, The Journal of Immunology.
[9] Y. Chwae,et al. Molecular Mechanism of the Activation-Induced Cell Death Inhibition Mediated by a p70 Inhibitory Killer Cell Ig-Like Receptor in Jurkat T Cells1 , 2002, The Journal of Immunology.
[10] R. Biassoni,et al. Identification of HLA-E-specific alloreactive T lymphocytes: A cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[11] R. Ahmed,et al. Viral and Bacterial Infections Induce Expression of Multiple NK Cell Receptors in Responding CD8+ T Cells1 , 2002, The Journal of Immunology.
[12] M. Weekes,et al. Identification of Naive or Antigen-Experienced Human CD8+ T Cells by Expression of Costimulation and Chemokine Receptors: Analysis of the Human Cytomegalovirus-Specific CD8+ T Cell Response1 , 2002, The Journal of Immunology.
[13] W. O'Fallon,et al. Formation of the Killer Ig-Like Receptor Repertoire on CD4+CD28null T Cells1 , 2002, The Journal of Immunology.
[14] M. Uhrberg,et al. KIR expression shapes cytotoxic repertoires: a developmental program of survival. , 2002, Trends in immunology.
[15] M. Daëron. Immunoreceptor Tyrosine Based Inhibition Motifs (ITIMs) , 2002 .
[16] S. Anfossi,et al. The analysis of the natural killer‐like activity of human cytolytic T lymphocytes revealed HLA‐E as a novel target for TCR α/β‐mediated recognition , 2001 .
[17] M. Caligiuri,et al. The biology of human natural killer-cell subsets. , 2001, Trends in immunology.
[18] É. Vivier,et al. Biology of T memory type 1 cells , 2001, Immunological reviews.
[19] D. Nixon,et al. Functional Heterogeneity of Cytokines and Cytolytic Effector Molecules in Human CD8+ T Lymphocytes1 , 2001, The Journal of Immunology.
[20] P. Parham,et al. The Repertoire of Killer Cell Ig-Like Receptor and CD94:NKG2A Receptors in T Cells: Clones Sharing Identical αβ TCR Rearrangement Express Highly Diverse Killer Cell Ig-Like Receptor Patterns1 , 2001, The Journal of Immunology.
[21] P. Parham,et al. Differential Expression of Leukocyte Receptor Complex-Encoded Ig-Like Receptors Correlates with the Transition from Effector to Memory CTL1 , 2001, The Journal of Immunology.
[22] S. Rowland-Jones,et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes , 2001, Nature.
[23] M. Bonneville,et al. Regulation of Inhibitory and Activating Killer-Cell Ig-Like Receptor Expression Occurs in T Cells After Termination of TCR Rearrangements1 , 2001, The Journal of Immunology.
[24] M. Colonna,et al. Ig-Like Transcript 2 (ILT2)/Leukocyte Ig-Like Receptor 1 (LIR1) Inhibits TCR Signaling and Actin Cytoskeleton Reorganization1 , 2001, The Journal of Immunology.
[25] G. Anastasi,et al. The CD85/LIR-1/ILT2 Inhibitory Receptor Is Expressed by All Human T Lymphocytes and Down-Regulates Their Functions1 , 2000, The Journal of Immunology.
[26] S. Chouaib,et al. Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas. , 2000, Blood.
[27] P. Marrack,et al. Control of homeostasis of CD8+ memory T cells by opposing cytokines. , 2000, Science.
[28] D. Speiser,et al. CD28‐negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients , 1999, European journal of immunology.
[29] J. Opferman,et al. Linear differentiation of cytotoxic effectors into memory T lymphocytes. , 1999, Science.
[30] M. Colonna,et al. A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells , 1997, The Journal of experimental medicine.
[31] M. Kubin,et al. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. , 1997, Immunity.
[32] R. Biassoni,et al. HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells. , 1997, International immunology.
[33] P. Coulie,et al. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. , 1997, Immunity.
[34] A. Fauci,et al. Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[35] L. Lanier,et al. Regulation of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles , 1996, The Journal of experimental medicine.
[36] P. Parham,et al. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. , 1995, Science.
[37] W. O'Fallon,et al. Formation of the Killer Ig-Like Receptor Repertoire on CD4 CD28 T Cells , 2002 .
[38] R. Vance,et al. Regulation of the natural killer cell receptor repertoire. , 2001, Annual review of immunology.
[39] K. Triantafilou,et al. Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells , 2001, Nature Immunology.
[40] Eric O Long,et al. Regulation of immune responses through inhibitory receptors. , 1999, Annual review of immunology.
[41] M. Bonneville,et al. Major Expansion of γδ T Lymphocytes following Cytomegalovirus Infection in Kidney Allograft Recipients , 1999 .
[42] S. Park,et al. Mouse CD1-specific NK1 T cells: development, specificity, and function. , 1997, Annual review of immunology.